Actualités - page 4 ABL DIAGNOSTICS

ABL Diagnostics (FR001400AHX6) ("ABLD" ou la "Société") a annoncé aujourd'hui que, depuis août 2023, trois cessions, pour un total de 59 651 de ses actions ordinaires, ont été déclarées à ONDE, le système central de dépôt d'informations de l'Autorité des Marchés ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the execution of an exclusive distribution agreement ... Lire la suite

▪ Access to a comprehensive Next Generation Sequencing (NGS) kit for HIV Whole Genome genotyping. ▪ Ability to screen genomic variations in all HIV-1 genome genes targeted by current and under development HIV-1 inhibitors. Newburyport (MA, USA) – AdvancedDx Biological ... Lire la suite

Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD) annonce la désignation du Dr Chalom Sayada, fondateur et CEO de la société Advanced Biological Laboratories (ABL), société-mère d’ABL Diagnostics, comme nouveau directeur général. Il remplace, à compter du ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release of its DeepChek®-HPV Assay for the screening, ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release of new versions of its CE-IVD (In Vitro ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce a major evolution of its research & development activities ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the release of new DeepChek® assays intended to be used ... Lire la suite

Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the expansion of its HIV genotyping menu of applications with ... Lire la suite